Literature DB >> 889597

Cytotoxic agents from Michelia champaca and Talauma ovata: parthenolide and costunolide.

J J Hoffmann, S J Torrance, R M Widehopf, J R Cole.   

Abstract

The ethanol extract of Michelia champaca and the petroleum ether extract of Talauma ovata showed activity toward the human epidermoid carcinoma of the nasopharynx test system. The active constituents were sesquiterpene lactones, identified as parthenolide (C15H20O3) and costunolide (C15H20O2). Their identities were proven by elemental analyses, PMR, IR, and mass spectral data, melting-point and mixed melting-point determinations, and comparisons with authentic samples and spectra.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 889597     DOI: 10.1002/jps.2600660642

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Sesquiterpene lactones and other constituents from a cytotoxic extract of Michelia floribunda.

Authors:  I O Mondranondra; C T Che; A M Rimando; S Vajrodaya; H H Fong; N R Farnsworth
Journal:  Pharm Res       Date:  1990-12       Impact factor: 4.200

2.  Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.

Authors:  Maria Zeniou; Marie Fève; Samir Mameri; Jihu Dong; Christophe Salomé; Wanyin Chen; Elias A El-Habr; Fanny Bousson; Mohamadou Sy; Julie Obszynski; Alexandre Boh; Pascal Villa; Suzana Assad Kahn; Bruno Didier; Dominique Bagnard; Marie-Pierre Junier; Hervé Chneiweiss; Jacques Haiech; Marcel Hibert; Marie-Claude Kilhoffer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

3.  New insights on the phytochemical intervention for the treatment of neuropsychiatric disorders using the leaves of Michelia champaca: an in vivo and in silico approach.

Authors:  Pushpa V H; Jayanthi M K; Rashmi H R; Veeresh Kumar N Shivamurthy; Shashank M Patil; Prithvi S Shirahatti; Ramith Ramu
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.